Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve 1. To consider and approve the Un - audited Financial Results along with LRR for the quarter ended December 31, 2023; 2. To confirm the closure of trading window from January 01, 2024 till the end of 48 hours after the Financials Results are made public; 3. Any other business matter with the permission of chair.